Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Current Leases: 2022-2024

Historic Current Leases for Immunocore Holdings (IMCR) over the last 3 years, with Dec 2024 value amounting to $1.5 million.

  • Immunocore Holdings' Current Leases rose 71.19% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 71.19%. This contributed to the annual value of $1.5 million for FY2024, which is 11.46% up from last year.
  • According to the latest figures from FY2024, Immunocore Holdings' Current Leases is $1.5 million, which was up 11.46% from $1.4 million recorded in FY2023.
  • Over the past 5 years, Immunocore Holdings' Current Leases peaked at $1.9 million during FY2022, and registered a low of $1.4 million during FY2023.
  • For the 3-year period, Immunocore Holdings' Current Leases averaged around $1.6 million, with its median value being $1.5 million (2024).
  • Per our database at Business Quant, Immunocore Holdings' Current Leases dropped by 26.25% in 2023 and then climbed by 11.46% in 2024.
  • Yearly analysis of 3 years shows Immunocore Holdings' Current Leases stood at $1.9 million in 2022, then declined by 26.25% to $1.4 million in 2023, then rose by 11.46% to $1.5 million in 2024.